Detalles de la búsqueda
1.
Cost-Effectiveness of Oral Nirmatrelvir/Ritonavir in Patients at High Risk for Progression to Severe COVID-19 in the United States.
Value Health
; 27(2): 164-172, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38043712
2.
Estimating the value of sodium-glucose cotransporter-2 inhibitors within the context of contemporary guidelines and the totality of evidence.
Diabetes Obes Metab
; 25(7): 1830-1838, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36864575
3.
Computer Modeling of Diabetes and Its Transparency: A Report on the Eighth Mount Hood Challenge.
Value Health
; 21(6): 724-731, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29909878
4.
Validation of the IMS CORE Diabetes Model.
Value Health
; 17(6): 714-24, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25236995
5.
Computer modeling of diabetes and its complications: a report on the Fifth Mount Hood challenge meeting.
Value Health
; 16(4): 670-85, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23796302
6.
External Validation of the Core Obesity Model to Assess the Cost-Effectiveness of Weight Management Interventions.
Pharmacoeconomics
; 38(10): 1123-1133, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32656686
7.
Long-term cost-effectiveness of pioglitazone versus placebo in addition to existing diabetes treatment: a US analysis based on PROactive.
Value Health
; 12(1): 1-9, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-18657104
8.
Cost-Effectiveness Analysis of Empagliflozin in Comparison to Sitagliptin and Saxagliptin Based on Cardiovascular Outcome Trials in Patients with Type 2 Diabetes and Established Cardiovascular Disease.
Diabetes Ther
; 10(6): 2153-2167, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-31602601
9.
Assessing the Burden of Type 2 Diabetes in China Considering the Current Status-Quo Management and Implications of Improved Management Using a Modeling Approach.
Value Health Reg Issues
; 18: 36-46, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-30419449
10.
Cost-effectiveness of basal insulin from a US health system perspective: comparative analyses of detemir, glargine, and NPH.
Adv Ther
; 23(2): 191-207, 2006.
Artículo
en Inglés
| MEDLINE | ID: mdl-16751153
11.
Authors' reply to Comment on "External Validation of the Core Obesity Model to Assess the Cost-Effectiveness of Weight Management Interventions".
Pharmacoeconomics
; 39(1): 137-138, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33251570
12.
Treating diabetes to accepted standards of care: a 10-year projection of the estimated economic and health impact in patients with type 1 and type 2 diabetes mellitus in the United States.
Clin Ther
; 27(6): 940-50, 2005 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-16117994
13.
Long-term clinical and cost outcomes of treatment with biphasic insulin aspart 30/70 versus insulin glargine in insulin naïve type 2 diabetes patients: cost-effectiveness analysis in the UK setting.
Curr Med Res Opin
; 21(12): 2063-71, 2005 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-16368057
14.
Insulin degludec early clinical experience: does the promise from the clinical trials translate into clinical practice--a case-based evaluation.
J Med Econ
; 18(2): 96-105, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25325179
15.
Economic impact of severe and non-severe hypoglycemia in patients with Type 1 and Type 2 diabetes in the United States.
J Med Econ
; 18(6): 420-32, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25629654
16.
The CORE Diabetes Model: Projecting long-term clinical outcomes, costs and cost-effectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and reimbursement decision-making.
Curr Med Res Opin
; 20 Suppl 1: S5-26, 2004 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-15324513
17.
Validation of the CORE Diabetes Model against epidemiological and clinical studies.
Curr Med Res Opin
; 20 Suppl 1: S27-40, 2004 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-15324514
18.
Comments on Long-term clinical and cost outcomes of treatment with biphasic insulin aspart 30/70 versus insulin glargine in insulin-naïve type 2 diabetes patients: cost-effectiveness analysis in the UK setting.
Curr Med Res Opin
; 22(5): 967-9; author reply 968-9, 2006 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-16709318
19.
Self-monitoring of blood glucose (SMBG) in patients with type 2 diabetes on oral anti-diabetes drugs: cost-effectiveness in France, Germany, Italy, and Spain.
Curr Med Res Opin
; 26(1): 163-75, 2010 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-19919377
20.
An economic assessment of analogue basal-bolus insulin versus human basal-bolus insulin in subjects with type 1 diabetes in the UK.
Curr Med Res Opin
; 23(4): 895-901, 2007 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-17407646